Company: SMNR
Filing Date: 2025-07-23
Form Type: S-4/A
Source: 0001193125-25-163401
Chunk: 381

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-07-23
Form: S-4/A
Chunk 381
---
 event that the Sponsor and/or their affiliates purchase Denali Class A Ordinary Shares, any such agreement or arrangement will (i) provide that the Sponsor and/or their affiliates will purchase the Denali Class A Ordinary Shares at a price no higher than the price offered through the redemption process, (ii) include a representation that any Denali Class A Ordinary Shares purchased by the Sponsor and/or their affiliates will not be voted in favor of approving the Business Combination, and (iii) provide that the Sponsor and/or their affiliates do not possess any redemption rights with respect to the Denali Class A Ordinary Shares or, if they possess redemption rights, they waive such rights. In addition, to the extent any such purchases are made by the Sponsors and/or their affiliates, Denali will disclose in a Current Report on Form 8–K, prior to the Meeting, the following information with respect to any such transaction: (a) the amount of Denali Class A Ordinary Shares purchased outside of the redemption offer by the Sponsors and/or their affiliates, along with the purchase price; (b) the purpose of the purchases by the Sponsor and/or their affiliates; (c) the impact, if any, of the purchases by the Sponsor and/or their affiliates on the likelihood that the business combination transaction will be approved; (d) the identities of security holders of Denali who sold to the Sponsor and/or their affiliates (if not purchased on the open market) or the nature of Denali’s security holders (e.g., 5% security holders) who sold to the Sponsor and/or their affiliates; and (e) the number of Denali Class A Ordinary Shares for which Denali has received redemption requests pursuant to its redemption offer. Vote Required for Approval The approval of the Business Combination Proposal requires an ordinary resolution under Cayman Islands law, being the affirmative vote of the majority of the Denali Ordinary Shares present in person or represented by proxy and entitled to vote thereon and who vote at the Meeting or any adjournment or postponement thereof. The Business Combination is conditioned on the approval of each of the other Condition Precedent Proposals. Pursuant to the Letter Agreement and the Sponsor Support Agreement, the Initial Shareholders holding an aggregate of 1,562,500 Denali Class B Ordinary Shares (or 59.7% of the outstanding Denali Class B Ordinary 218

Shares have agreed to attend the Meeting and vote their respective Denali Class B Ordinary Shares) in favor of each of the Proposals. As a result, no Den